The genetic mutation that causes Huntington's disease (HD)—a devastating brain disease that disrupts mobility and diminishes ...

A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.

Researchers uncover a link between impaired glutathione–ascorbate metabolism and early dopamine increases in Huntington's ...

The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...

Bayer has become the latest in a long line of drug developers to give up on Huntington’s disease after the German pharma ...

The show is a joint project by artists Bert and Elise Holland, Charlotte, Clair, Evie, Kate, Spencer James and Steven Hart.

Scientists at Northwestern and Case Western Reserve universities have developed the first polymer-based therapeutic for ...

Breakthrough polymer-based therapy shows promise in reversing Huntington's disease symptoms by preventing toxic protein ...

Huntington's disease is a devastating, fatal neurological illness with little means of treatment, but a new study in mice ...

A polymer has been developed to optimize the use of a peptide to treat Huntington’s disease in mice.

Engineered polymers interfere with protein interactions to protect cell health in a mouse study. Researchers at Northwestern University and Case Western Reserve University have developed the first ...

New Approach to Fight Huntington's Disease Shows Early Promise By Ernie Mundell HealthDay Reporter MONDAY, Nov. 4, 2024 (HealthDay News) -- Huntington's disease is a devastating, fatal ...